Table 1 hBM-MSC growth (fold increase) and viability (%) according to the expansion phase. Fold increase and viability were assessed from P0 to P3 passages.

From: Intravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice

 

P0

P1

P2

P3

Fold increase*

n.a.

176.5 (±41.12)

182.8 (±88.86)

132.5 (±63.98)

Viability*

89.3% (±1.44)

95.4% (±0.68)

96.2% (±1.41)

93.0% (±0.99)

  1. *Values are expressed as mean ± SE of four distinct hBM-MSC expansion experiments obtained from distinct sources.
Back to article page